Passive antibody therapy in COVID-19.

Abraham, Jonathan

Abraham, Jonathan.

Abraham J; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA. jonathan_abraham@hms.harvard.edu.

Nat Rev Immunol ; 20(7): 401-403, 2020 07.

Article in English | MEDLINE | ID: covidwho-597205

Subject(s)

Antibodies, Monoclonal/administration & dosage; Coronavirus Infections/immunology; Coronavirus Infections/therapy; Pneumonia, Viral/immunology; Pneumonia, Viral/therapy; Animals; Antibodies, Monoclonal/immunology; Antibodies, Neutralizing/immunology; Antibodies, Viral/administration & dosage; Antibodies, Viral/immunology; Betacoronavirus; COVID-19; Humans; Immunization, Passive; Pandemics; SARS-CoV-2; Spike Glycoprotein, Coronavirus/immunology; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antibodies, Monoclonal Limits: Animals / Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-0365-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google